Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mebea Aklilu

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The American Surgeon|April 12, 2013
Optimal timing of systemic therapy in resectable colorectal liver metastasesChukwuemeka Ihemelandu, Edward A Levine, Mebea Aklilu, et al.
Complementary Therapies in Medicine|March 16, 2016
A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot studyStephanie J Sohl, Suzanne C Danhauer, Gurjeet S Birdee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?Arta Monir Monjazeb, Greg Riedlinger, Mebea Aklilu, et al.
American Journal of Clinical Oncology|May 2, 2012
A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinomaLaura Raftery, Joel E Tepper, Richard M Goldberg, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinomaDaniel M Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, et al.
Anticancer Research|January 29, 2011
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancerNan Soon Wong, Nishan H Fernando, Andrew B Nixon, et al.
Journal of Neurosurgery|March 6, 2012
The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgeryD Clay Cochran, Michael D Chan, Mebea Aklilu, et al.
Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The American Surgeon|April 12, 2013
Optimal timing of systemic therapy in resectable colorectal liver metastasesChukwuemeka Ihemelandu, Edward A Levine, Mebea Aklilu, et al.
Complementary Therapies in Medicine|March 16, 2016
A brief yoga intervention implemented during chemotherapy: A randomized controlled pilot studyStephanie J Sohl, Suzanne C Danhauer, Gurjeet S Birdee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?Arta Monir Monjazeb, Greg Riedlinger, Mebea Aklilu, et al.
American Journal of Clinical Oncology|May 2, 2012
A two-cohort phase I study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine, and erlotinib during radiotherapy for unresectable pancreatic carcinomaLaura Raftery, Joel E Tepper, Richard M Goldberg, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinomaDaniel M Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, et al.
Anticancer Research|January 29, 2011
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancerNan Soon Wong, Nishan H Fernando, Andrew B Nixon, et al.
Journal of Neurosurgery|March 6, 2012
The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgeryD Clay Cochran, Michael D Chan, Mebea Aklilu, et al.
Annals of Surgery|May 10, 2013
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancerMichael A Morse, Donna Niedzwiecki, John L Marshall, et al.
Pageof 2